In type 2 diabetes, glargine and liraglutide each improved glycemic outcomes at 5 y vs. glimepiride or sitagliptin.
Where this comes from
- Record sourced from PubMed, PMID 36592465.
- Also identified by DOI 10.7326/J22-0104.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GRADE Study Research Group; Nathan DM, Lachin JM, Balasubramanyam A, et al. <b>Glycemia reduction in type 2 diabetes-glycemic outcomes.</b> N Engl J Med. 2022;387:1063-74. 36129996.
Medical subject headings
- Diabetes Mellitus, Type 2
- Metformin